Literature DB >> 18832671

Cutting edge: TLR ligands increase TCR triggering by slowing peptide-MHC class I decay rates.

Brian D Rudd1, James D Brien, Miles P Davenport, Janko Nikolich-Zugich.   

Abstract

TLR ligands are among the key stimuli driving the optimal dendritic cell (DC) maturation critical for strong and efficacious T cell priming. In this study, we show that part of this effect occurs via increased TCR triggering. Pretreatment of DCs with TLR ligands resulted in the triggering of many more TCRs in responding CD8(+) T cells. Importantly, even when DCs expressed the same amount of cognate peptide-MHC (pMHC) molecules, TLR ligand treatment resulted in down-regulation of larger numbers of TCR molecules. This was independent of the up-regulation of costimulatory, adhesion or cytokine molecules or the amount of noncognate pMHCs. Rather, DCs pretreated with TLR ligands exhibited increased stability of cognate pMHCs, enabling extended TCR triggering. These findings are of potential importance to T cell vaccination.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18832671      PMCID: PMC2728084          DOI: 10.4049/jimmunol.181.8.5199

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells.

Authors:  L Van Kaer; P G Ashton-Rickardt; H L Ploegh; S Tonegawa
Journal:  Cell       Date:  1992-12-24       Impact factor: 41.582

2.  T cell activation determined by T cell receptor number and tunable thresholds.

Authors:  A Viola; A Lanzavecchia
Journal:  Science       Date:  1996-07-05       Impact factor: 47.728

Review 3.  Antigen-specific T-cell receptors and their reactions with complexes formed by peptides with major histocompatibility complex proteins.

Authors:  H N Eisen; Y Sykulev; T J Tsomides
Journal:  Adv Protein Chem       Date:  1996

Review 4.  Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition.

Authors:  S Valitutti; A Lanzavecchia
Journal:  Immunol Today       Date:  1997-06

5.  Kinetic proofreading in T-cell receptor signal transduction.

Authors:  T W McKeithan
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

6.  Characterization of two TCR transgenic mouse lines specific for herpes simplex virus.

Authors:  Scott N Mueller; WilliamR Heath; Julie D McLain; Francis R Carbone; Claerwen M Jones
Journal:  Immunol Cell Biol       Date:  2002-04       Impact factor: 5.126

7.  Activated TCRs remain marked for internalization after dissociation from pMHC.

Authors:  Daniel Coombs; Alexis M Kalergis; Stanley G Nathenson; Carla Wofsy; Byron Goldstein
Journal:  Nat Immunol       Date:  2002-09-09       Impact factor: 25.606

8.  Serial triggering of many T-cell receptors by a few peptide-MHC complexes.

Authors:  S Valitutti; S Müller; M Cella; E Padovan; A Lanzavecchia
Journal:  Nature       Date:  1995-05-11       Impact factor: 49.962

9.  CD4-independent in vivo priming of murine CTL by optimal MHC class I-restricted peptides derived from intracellular pathogens.

Authors:  R Dyall; L V Vasović; A Molano; J Nikolić-Zugić
Journal:  Int Immunol       Date:  1995-08       Impact factor: 4.823

10.  Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy.

Authors:  S Valitutti; S Müller; M Dessing; A Lanzavecchia
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

View more
  7 in total

Review 1.  The effect of ageing on macrophage Toll-like receptor-mediated responses in the fight against pathogens.

Authors:  C R Dunston; H R Griffiths
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

Review 2.  Properties and applications of single-chain major histocompatibility complex class I molecules.

Authors:  Eleni Kotsiou; Joanna Brzostek; Keith G Gould
Journal:  Antioxid Redox Signal       Date:  2011-03-31       Impact factor: 8.401

3.  Different interleukin-17-secreting Toll-like receptor+ T-cell subsets are associated with disease activity in multiple sclerosis.

Authors:  Thais B Ferreira; Joana Hygino; Ana Cristina Wing; Taissa M Kasahara; Priscila M Sacramento; Solange Camargo; Fernanda Rueda; Soniza V Alves-Leon; Regina Alvarenga; Claudia Cristina Vasconcelos; Anshu Agrawal; Sudhir Gupta; Cleonice A M Bento
Journal:  Immunology       Date:  2017-12-26       Impact factor: 7.397

4.  Characterizing the dynamics of CD4+ T cell priming within a lymph node.

Authors:  Jennifer J Linderman; Thomas Riggs; Manjusha Pande; Mark Miller; Simeone Marino; Denise E Kirschner
Journal:  J Immunol       Date:  2010-02-12       Impact factor: 5.422

5.  Multiple-Allele MHC Class II Epitope Engineering by a Molecular Dynamics-Based Evolution Protocol.

Authors:  Rodrigo Ochoa; Victoria Alves Santos Lunardelli; Daniela Santoro Rosa; Alessandro Laio; Pilar Cossio
Journal:  Front Immunol       Date:  2022-04-27       Impact factor: 8.786

6.  Dendritic cells matured by inflammation induce CD86-dependent priming of naive CD8+ T cells in the absence of their cognate peptide antigen.

Authors:  Asher Maroof; Lynette Beattie; Alun Kirby; Mark Coles; Paul M Kaye
Journal:  J Immunol       Date:  2009-11-16       Impact factor: 5.422

7.  A TLR9 agonist enhances the anti-tumor immunity of peptide and lipopeptide vaccines via different mechanisms.

Authors:  Ying-Chyi Song; Shih-Jen Liu
Journal:  Sci Rep       Date:  2015-07-28       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.